MINNEAPOLIS, May 14, 2020 /PRNewswire/ --The challenges surrounding COVID-19 have impacted every aspect of healthcare, including ensuring the timely delivery of bone marrow and blood stem cells for transplant. Thanks to the generosity of the Lockheed Martin Corporation, however, patients are able to continue receiving life-saving transplants without interruption.
When the National Marrow Donor Program (NMDP)/Be The Match ran out of available European Union couriers to deliver life-saving cells to American patients and with tens of thousands of commercial flights canceled, Lockheed Martin stepped up to offer their corporate aircraft as an in-kind donation to support the federal government's COVID-19 response and relief efforts to ensure patients that life-saving products from European donors would arrive on time.
NMDP/Be The Match, operates the federally authorized program that matches unrelated volunteer donors with patients in the United States and abroad who have been diagnosed with leukemia and over 70 more otherwise fatal blood disorders and diseases.
In addition to matching donors and patients, one of the program's primary missions is coordinating the delivery of bone marrow domestically and internationally to patients in the United States and abroad. This life-or-death delivery has historically been accomplished by trained couriers hand carrying donated marrow in the passenger compartment of commercial aircraft from donor collection centers to the hospitals of patients all across the globe.
Patients who are scheduled to receive transplants in the coming days are already in the process of a carefully timed course of chemotherapy and radiation treatments designed to eliminate their existing immune systems in preparation for the transplantation of cells to create a healthy, new immune system. If the transportation of donor cells is interrupted, the consequences are fatal to these patients whose immune systems have been ablated.
"The incredible support from Lockheed Martin is a lifeline to our patients. For those awaiting bone marrow transplant, their very survival depends on the on-time delivery of these life-saving cells. By offering flight services, Lockheed Martin is helping us ensure that patients can continue the cells they need, exactly when they need them," said NMDP/Be The Match Chief Policy Officer Brian Lindberg.
As part of this partnership Lockheed Martin will be providing weekly air transport based on government medical need flying government medical teams to the most critical, high-priority locations around the country and/or flying to support bone marrow transport to help with the government's COVID-19 response.
NMDP/Be The Match has facilitated over 100,000 bone marrow transplants since 1987 to deliver cures for patients battling blood cancers and blood disorders. More than 50 percent of those transplants involve international donors or recipients.
About Be The MatchFor people with life-threatening blood cancerslike leukemia and lymphomaor other diseases, a cure exists. Be The Match connects patients with their donor match for a life-saving marrow or umbilical cord blood transplant. People can contribute to the cure as a member of the Be The Match Registry, financial contributor or volunteer. Be The Match provides patients and their families one-on-one support, education, and guidancebefore, during and after transplant.
Be The Match is operated by the National Marrow Donor Program (NMDP), a nonprofit organization that matches patients with donors, educates health care professionals and conducts research through its research program, CIBMTR (Center for International Blood and Marrow Transplant Research), so more lives can be saved. To learn more about the cure, visit BeTheMatch.orgor call 1 (800) MARROW-2.
View original post here:
- LMRUK: New mothers share why theyre banking their babies cord blood stem cells - Charity Today News - November 29th, 2024
- scRNA-seq revealed transcriptional signatures of human umbilical cord primitive stem cells and their germ lineage origin regulated by imprinted genes... - November 26th, 2024
- Cord Blood Banking FAQs - Cord For Life - November 25th, 2024
- Hematopoietic Stem Cell Transplantation Market: Industry Analysis and Forecast 2024-2033 - openPR - November 22nd, 2024
- Thousands of donations, fewer than 2% used. Why cord blood transplants are so rare - CBC News - November 18th, 2024
- Stem cells: the alternative solution to umbilical cord blood - Genethique - November 10th, 2024
- Chapter 64 Role of Umbilical Cord Blood Transplantation - October 30th, 2024
- Major Trend Transforming the Stem Cell Market in 2024: Advancements in Automated Stem Cell Analysis Systems - EIN News - October 30th, 2024
- Stem cell therapies for neurological disorders: current progress ... - October 22nd, 2024
- OmniaBio Announces Opening of New Commercial Manufacturing Facility in Canada, Bringing Life-Saving Cell and Gene Therapies to Patients - AsiaOne - October 18th, 2024
- Click N' Play STEM Lesson on Cord Blood Launches for Teachers this November - EIN News - October 18th, 2024
- Black, White Cancer Patients Now Benefit Equally From Cord Blood Therapy - HealthDay - October 4th, 2024
- What Are Leukemia and Lymphoma and How Are They Treated? - LVHN News - September 20th, 2024
- Advanced Treatment for Leukemia and Lymphoma at Lehigh Valley Topper Cancer Institute - LVHN News - September 18th, 2024
- Functional stem cells successfully grown in lab for the first time - The Star Online - September 14th, 2024
- Umbilical Cord Blood Stem Cells as Third-party Adjuvant Infusions in Human Leukocyte Antigen Antibody-Positive Patients Undergoing Haploidentical... - September 12th, 2024
- Cord Blood Banking Market Size to Surpass USD 65.6 Billion by 2032 | With 7.9% CAGR - openPR - September 12th, 2024
- Blood stem cell breakthrough could have massive impact on patients - Yahoo! Voices - September 8th, 2024
- Scientists have grown blood stem cells in the laboratory - TURKMENPORTAL - September 4th, 2024
- Global Cord Blood Product Market Poised for Significant Growth: Projected to Reach USD 1,341.7 Million by 2034 | Future Market Insights, Inc. - Yahoo... - September 2nd, 2024
- Global Allogeneic Stem Cell Transplantation Market Expected to Grow to $6.75 Billion by 2031 - WhaTech - August 31st, 2024
- Global Cord Blood Product Market Poised for Significant Growth: Projected to Reach USD 1,341.7 Million by 2034 | Future Market Insights, Inc. -... - August 31st, 2024
- Expansion Of Cord Blood-derived CD34 Cells In A Hollow-Fiber Bioreactor With 10% Standard Cytokine Concentration - BioProcess Online - August 22nd, 2024
- New Study: These Bizarre Blood-Sucking Fish Have a Jaw-Dropping Evolutionary Origin - SciTechDaily - July 31st, 2024
- Cord blood banking industry faces scrutiny over unproven claims and high costs - News-Medical.Net - July 28th, 2024
- Stem cells donated 15 years ago let poorly boy, five, leave home for the first time in six months - Express & Star - July 26th, 2024
- Cord blood stem cells transferred from Guangdong to treat girl with thalassemia - Hong Kong Standard - July 26th, 2024
- Cord Blood Banking Curative Benefits Often Oversold to Parents: NYT Investigation - AboutLawsuits.com - July 22nd, 2024
- Umbilical cord stem cells donated in 2008 transform life of five-year-old boy with rare genetic disorder - The Independent - July 22nd, 2024
- Boy, 5, diagnosed with deadly rare condition has life transformed after stem cell transplant from umbilical cord blood - Sky News - July 22nd, 2024
- Stem cells donated 15 years ago let poorly boy, five, leave home for the first time in six months - Shropshire Star - July 22nd, 2024
- Ottawa mother raising awareness on importance of donating umbilical cord blood - CTV News Ottawa - July 22nd, 2024
- Inside a blood cord bank: How facilities store and maintain the quality of units - CNA - July 8th, 2024
- Exploring the potential of predicted miRNAs on the genes involved in the expansion of hematopoietic stem cells ... - Nature.com - July 5th, 2024
- Overview of Umbilical Cord Blood - Stanford Medicine - July 5th, 2024
- Comparison of the therapeutic effects of human umbilical cord blood-derived mesenchymal stem cells and adipose ... - Frontiers - July 5th, 2024
- A Review of Placenta and Umbilical Cord-Derived Stem Cells and the Immunomodulatory Basis of Their Therapeutic ... - Frontiers - July 2nd, 2024
- Jacques Galipeau, MD, on International Insights Into Cell and Gene Therapy Development - CGTLive - June 30th, 2024
- Stem Cell Therapy Market to Hit $63.23 billion by 2031, at a CAGR of 22.6%, says Coherent Market Insights - GlobeNewswire - June 28th, 2024
- Hematopoietic stem cell transplantation (HSCT) Market Future Growth Trends, Upcoming Opportunities and ... - openPR - June 24th, 2024
- Global Biopreservation Market Forecast Report 2024-2029: Advances in Biobanking and Growing Trend of Conserving ... - GlobeNewswire - June 4th, 2024
- Cord Blood Banking Services Market to Witness Impressive Growth, Reaching USD 4.5 Billion by 2030 - EIN News - May 27th, 2024
- Department of Health Abu Dhabi and M42 launch regions largest hybrid cord blood bank - ZAWYA - May 15th, 2024
- Cord Blood Banking - Stanford Medicine Children's Health - May 8th, 2024
- Umbilical Cord Blood Transplants: Current Status and Evolving Therapies - May 8th, 2024
- Embattled Cordlife receives letter of demand from client for breach of contract - The Straits Times - May 4th, 2024
- From Cord Blood to Microbiome; The evolution of Rotary's gift to the people of WA - Lifeblood - May 2nd, 2024
- Efficacy and safety of human umbilical cord-derived mesenchymal stem cells in the treatment of refractory immune ... - Nature.com - April 28th, 2024
- Hitting the pavement for cord blood research | Cranbourne Star News - Cranbourne Star News - April 28th, 2024
- One year to test 200 Cordlife samples 'totally unjustified': Global cord blood banking experts - The Straits Times - April 15th, 2024
- Clinical trial: First cardiac bioimplants for treatment of myocardial infarction using umbilical cord stem cells - Medical Xpress - April 7th, 2024
- The umbilical cord: a rich and ethical stem cell source to advance ... - March 30th, 2024
- Story of discovery: getting a Notch up on cord blood cell ... - March 30th, 2024
- Cord Blood Transplants | Memorial Sloan Kettering Cancer Center - March 30th, 2024
- Therapeutic effect and study of human umbilical cord blood mononuclear cells in patients with ischaemic bowel ... - Nature.com - March 17th, 2024
- Global Cord Blood & Tissue Banking Industry Report 2024: The Vast Majority of the Global Cord Blood Market is Now ... - PR Newswire - March 15th, 2024
- Improving Transplant Outcomes and Cell Therapy Approaches - RegMedNet - March 9th, 2024
- The inhibition of ADAM17 in cord blood stem cell-derived CD16+ NK cells to enhance their cytotoxicity against acute ... - ScienceDirect.com - March 1st, 2024
- Beating Blood Cancer through Recycling - a Community crowdfunding project in Liverpool by Kate Williams - Crowdfunder UK - February 24th, 2024
- Cord Blood Registry (CBR ) by CooperSurgical and Fulgent Genetics Launch Innovative Genetic Testing - Investing.com Canada - February 9th, 2024
- Young cancer patient with 'no hope' of recovery saved by baby's umbilical cord - Study Finds - February 9th, 2024
- Global Cord Blood & Tissue Banking Industry Report 2024 - The Vast Majority of the Global Cord Blood Market is Now ... - ACROFAN - January 26th, 2024
- Finding the optimal combination of anticancer drug administration for the conditioning of cord blood transplantation - Medical Xpress - January 26th, 2024
- Cord Blood Banking Market Sales and Revenue Report 2023-2032 - WhaTech Technology and Markets News - January 26th, 2024
- Global Cord Blood & Tissue Banking Industry Report 2024 - The Vast Majority of the Global Cord Blood Market is Now ... - ACROFAN USA - January 24th, 2024
- Global Biobanking Market Size To Exceed USD 97.5 Billion By 2032 | CAGR of 5.8% - GlobeNewswire - January 24th, 2024
- The use of cryopreservation in life saving research - The Manufacturer - January 24th, 2024
- CD19-targeted CAR NK cell therapy achieves promising one-year results in patients with B-cell malignancies - Medical Xpress - January 18th, 2024
- Cord blood banking comes at a high cost to babies - STAT - STAT - January 18th, 2024
- Global Cord Blood and Tissue Banking Industry Gains Traction Amidst Surging M&A Activity and Technological Advances - PR Newswire - January 16th, 2024
- Donating Bone Marrow and Stem Cells: The Process and What To Expect - On Cancer - Memorial Sloan Kettering - January 11th, 2024
- Ask the doctors: Research being conducted on using stem cells to treat diabetes - The Spokesman Review - January 4th, 2024
- askST: Can cord blood units be transferred from one bank to another? - The Straits Times - December 27th, 2023
- Timeline: Cordlife's mishandling of cord blood units in Singapore - CNA - December 15th, 2023
- Next-Level Evolution: Enhancing the Human Body With Anthrobots ... - Securities.io - December 5th, 2023
- Fred Hutch at ASH: Gene therapies for sickle cell, how to improve ... - Fred Hutchinson Cancer Center - December 5th, 2023
- Enhancing the immunosuppressive properties of human umbilical ... - Phys.org - December 1st, 2023
- Global Status and Trends for Thromboangiitis Obliterans | JPR - Dove Medical Press - December 1st, 2023
- Early Stage Cell Therapy Trial Shows Promise in Treating Progressive Multiple Sclerosis - University of Colorado Anschutz Medical Campus - December 1st, 2023
- Global Medical Specialty Bag Market is Expected to Reach US$ 9.4 Billion by 2034, Rising at a Steady 4.7% CAGR | Future Market Insights, Inc. - Yahoo... - November 29th, 2023
Recent Comments